Search results
NYU Langone offers the COVID-19 vaccine to our patients age 6 months and older. To learn more about the COVID-19 vaccine and vaccine safety, read our COVID-19 vaccine information for patients. Important Vaccine Information and Considerations.
- COVID-19 Vaccine Information for Patients - NYU Langone Health
NYU Langone offers patients 6 months and older the COVID-19...
- U.S. Clinical Trial for COVID-19 Vaccine Starts at NYU Langone Health
The first U.S. patients have been dosed in a clinical trial...
- COVID-19 Vaccine Information for Patients - NYU Langone Health
NYU Langone offers patients 6 months and older the COVID-19 vaccine, including updated boosters. Here are answers to some of your questions about the safety of the vaccine, how it works, and who should get vaccinated and why.
5 maj 2020 · The first U.S. patients have been dosed in a clinical trial testing whether four experimental messenger RNA (mRNA) vaccine candidates can prevent infection with the virus that causes 2019 coronavirus disease (COVID-19).
We protect and restore human health through innovative vaccine research. NYU Langone Health’s Vaccine Center, directed by Mark J. Mulligan, MD, leads pioneering vaccine-related research.
In response to the COVID-19 pandemic, we successfully led the development of effective vaccines and treatments to combat infection with SARS-CoV-2, the virus that causes COVID-19.
There is good news: the updated vaccine is widely available, free, well-tolerated, and safe. Below I list eight reasons, and links to some of the new supporting data, for why I strongly recommend that you stay up-to-date with your protection against Covid-19 by receiving the booster vaccine.
28 lip 2020 · NYU Langone Health was chosen as a trial center in part because of Dr. Mulligan's expertise in infectious disease research programs that have over decades assessed investigational vaccines...
